Founded in 2011, Lixoft develops modeling and simulation software for advanced model-based drug development. Its products offer powerful and easy solutions for population analysis in pre-clinical, clinical trials and in treatment individualization. Its R&D team includes software developers, statisticians, mathematicians and pharmacologists. Lixoft products are designed to save the time and energy of pharmacometricians and biostatisticians and to break the preclinical/clinical/vigilance divides for modelling and simulation, and allow all stages of drug development to share informations and synthesize them in common studies. The Monolix Suite is a unique population PKPD modeling solution for pharmacometrics experts. It allows to take a modeling project from the first data exploration up to clinical trial simulations.